Literature DB >> 18072586

The costs of using unauthenticated, over-passaged cell lines: how much more data do we need?

Peyton Hughes1, Damian Marshall, Yvonne Reid, Helen Parkes, Cohava Gelber.   

Abstract

Increasing data demonstrate that cellular cross-contamination, misidentified cell lines, and the use of cultures at high-passage levels contribute to the generation of erroneous and misleading results as well as wasted research funds. Contamination of cell lines by other lines has been recognized and documented back to the 1950s. Based on submissions to major cell repositories in the last decade, it is estimated that between 18% and 36% of cell lines may be contaminated or misidentified. More recently, problems surrounding practices of over-subculturing cells are being identified. As a result of selective pressures and genetic drift, cell lines, when kept in culture too long, exhibit reduced or altered key functions and often no longer represent reliable models of their original source material. A review of papers showing significant experimental variances between low- and high-passage cell culture numbers, as well as contaminated lines, makes a strong case for using verified, tested cell lines at low- or defined passage numbers. In the absence of cell culture guidelines, mandates from the National Institutes of Health (NIH) and other funding agencies or journal requirements, it becomes the responsibility of the scientific community to perform due diligence to ensure the integrity of cell cultures used in research.

Mesh:

Year:  2007        PMID: 18072586     DOI: 10.2144/000112598

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  130 in total

1.  Quality of Cell Products: Authenticity, Identity, Genomic Stability and Status of Differentiation.

Authors:  Kurt E J Dittmar; Meike Simann; Nadia Zghoul; Oliver Schön; Wilhelm Meyring; Horst Hannig; Lars Macke; Wilhelm G Dirks; Konstantin Miller; Henk S P Garritsen; Werner Lindenmaier
Journal:  Transfus Med Hemother       Date:  2010-03-08       Impact factor: 3.747

Review 2.  Development, characterization, conservation and storage of fish cell lines: a review.

Authors:  W S Lakra; T Raja Swaminathan; K P Joy
Journal:  Fish Physiol Biochem       Date:  2010-07-06       Impact factor: 2.794

3.  Establishment and characterization of a Madin-Darby canine kidney reporter cell line for influenza A virus assays.

Authors:  M Jaber Hossain; Sandra Perez; Zhu Guo; Li-Mei Chen; Ruben O Donis
Journal:  J Clin Microbiol       Date:  2010-05-26       Impact factor: 5.948

4.  siRNA knock-down of RANK signaling to control osteoclast-mediated bone resorption.

Authors:  Yuwei Wang; David W Grainger
Journal:  Pharm Res       Date:  2010-03-24       Impact factor: 4.200

5.  Development of genomic reference materials for cystic fibrosis genetic testing.

Authors:  Victoria M Pratt; Michele Caggana; Christina Bridges; Arlene M Buller; Lisa DiAntonio; W Edward Highsmith; Leonard M Holtegaard; Kasinathan Muralidharan; Elizabeth M Rohlfs; Jack Tarleton; Lorraine Toji; Shannon D Barker; Lisa V Kalman
Journal:  J Mol Diagn       Date:  2009-04-09       Impact factor: 5.568

6.  "Thyroid cancer" cell line misidentification: a time for proactive change.

Authors:  Matthew D Ringel
Journal:  J Clin Endocrinol Metab       Date:  2008-11       Impact factor: 5.958

7.  UM-SCC-103: a unique tongue cancer cell line that recapitulates the tumorigenic stem cell population of the primary tumor.

Authors:  John H Owen; Samantha J Hauff; Alice L Tang; Martin P Graham; Michael J Czerwinski; Marcella Kaddoura; Silvana Papagerakis; Carol R Bradford; Thomas E Carey; Mark E P Prince
Journal:  Ann Otol Rhinol Laryngol       Date:  2014-05-09       Impact factor: 1.547

Review 8.  Potential utility and limitations of thyroid cancer cell lines as models for studying thyroid cancer.

Authors:  Tania Pilli; Kanteti V Prasad; Shankar Jayarama; Furio Pacini; Bellur S Prabhakar
Journal:  Thyroid       Date:  2009-12       Impact factor: 6.568

9.  Overview of human primary tumorgraft models: comparisons with traditional oncology preclinical models and the clinical relevance and utility of primary tumorgrafts in basic and translational oncology research.

Authors:  David H Lum; Cindy Matsen; Alana L Welm; Bryan E Welm
Journal:  Curr Protoc Pharmacol       Date:  2012-12

10.  Effect of growth factors on the proliferation and gene expression of human meibomian gland epithelial cells.

Authors:  Shaohui Liu; Wendy R Kam; Juan Ding; Mark P Hatton; David A Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-04-05       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.